Table of Contents | Words: Alphabetical - Frequency - Inverse - Length - Statistics | Help | IntraText Library
Alphabetical    [«  »]
anti-graft 3
anti-mu 1
anti-pig 2
antibodies 21
antibody 3
anticomplement 1
antigen 1
Frequency    [«  »]
22 use
21 7
21 all
21 antibodies
21 case
21 his
21 pigs
Pontifical Academy for Life
Prospects for xenotransplantation

IntraText - Concordances

antibodies

   Part, Chapter, Paragraph
1 I, 1,1(10)| W., et al., The role of antibodies in acute vascular rejection 2 I, 2,2 | by xenoreactive natural antibodies and complement of the recipient 3 I, 2,2 | of elicited xenoreactive antibodies and activated host natural 4 I, 2,2 | stimuli (the anti-graft antibodies and the activated host cells) 5 I, 2,2 | Recipient xenoreactive natural antibodies and complement are the two 6 I, 2,2 | Pre-existing xenoreactive natural antibodies bind with vascular endothelial 7 I, 2,2 | the pig organ.(13) These antibodies are directed primarily towards 8 I, 2,2 | as "a-gal".(14) The bound antibodies fix and activate complement, 9 I, 2,2 | with the combination of antibodies and activated complement 10 I, 2,2 | of xenoreactive natural antibodies provides one method to overcome 11 I, 2,2(14)| which bind human antiporcine antibodiesimplications for discordant 12 I, 2,2(14)| L., et al., Anti-pig IgM antibodies in human serum react predominantly 13 I, 2,2(15)| antiporcine IgG and IgM natural antibodies by immunoadsorptionResults 14 I, 2,2(15)| IgM xenoreactive natural antibodies by injection of anti-mu 15 I, 2,2(15)| injection of anti-mu monoclonal antibodies, Immunol Rev 1994, 141:  16 I, 2,2 | by elicited xenoreactive antibodies and by the possible infiltration 17 I, 2,3 | preformed xenoreactive natural antibodies to reject a mouse or hamster 18 I, 2,3 | synthesis of anti-graft antibodies that, together with recipient 19 I, 2,3 | the presence of anti-graft antibodies and complement. Short-term 20 I, 2,3(30)| the presence of anti-donor antibodies and complement that precipitate 21 I, 2,3(31)| al., Preformed cytotoxic antibodies and ABO-incompatible grafts,


Best viewed with any browser at 800x600 or 768x1024 on Tablet PC
IntraText® (V89) - Some rights reserved by EuloTech SRL - 1996-2007. Content in this page is licensed under a Creative Commons License